Ulcerative colitis medications help control the symptoms of ulcerative colitis (UC) and prevent flare-ups or relapses. UC is a chronic inflammatory bowel disease. It's an autoimmune condition ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...

Extraintestinal manifestations happen when other tissues and organ systems are affected by UC-related inflammation or when the medications used to treat UC cause side effects outside the ...

Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...

Unfortunately, ulcerative colitis can occur in anyone, including pregnant women. But that does not mean you do not plan for a family. With proper management and treatment, women can experience a ...

The key Ulcerative Colitis therapies expected to launch in the market include Jyseleca (filgotinib), Rinvoq (Upadacitinib), ...